vs
卡地纳健康（CAH）与威瑞森（VZ）财务数据对比。点击上方公司名可切换其他公司
卡地纳健康的季度营收约是威瑞森的1.9倍（$65.6B vs $34.4B），威瑞森净利率更高（14.9% vs 0.7%，领先14.2%），卡地纳健康同比增速更快（19.6% vs 2.9%），过去两年卡地纳健康的营收复合增速更高（6.9% vs 2.5%）
卡地纳健康是美国跨国医疗服务企业，位列美国企业营收榜第15位，总部位于俄亥俄州都柏林。公司主营药品及医疗产品分销业务，服务覆盖超10万个网点，同时生产手套、手术服、流体管理产品等医疗及外科用品。
威瑞森通信是总部位于美国纽约的电信巨头，按营收规模为全球第二大电信企业，旗下移动网络是美国最大的无线通信运营商，截至2025年6月30日，在美订阅用户总数达1.461亿。
CAH vs VZ — 直观对比
营收规模更大
CAH
是对方的1.9倍
$34.4B
营收增速更快
CAH
高出16.7%
2.9%
净利率更高
VZ
高出14.2%
0.7%
两年增速更快
CAH
近两年复合增速
2.5%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $65.6B | $34.4B |
| 净利润 | $467.0M | $5.1B |
| 毛利率 | 3.7% | — |
| 营业利润率 | 1.1% | 23.9% |
| 净利率 | 0.7% | 14.9% |
| 营收同比 | 19.6% | 2.9% |
| 净利润同比 | -7.7% | 3.3% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CAHVZ
| Q1 26 | — | $34.4B | ||
| Q4 25 | $65.6B | $36.4B | ||
| Q3 25 | — | $33.8B | ||
| Q2 25 | $60.2B | $34.5B | ||
| Q1 25 | $54.9B | $33.5B | ||
| Q4 24 | $55.3B | $35.7B | ||
| Q3 24 | $52.3B | $33.3B | ||
| Q2 24 | $59.7B | $32.8B |
净利润CAHVZ
| Q1 26 | — | $5.1B | ||
| Q4 25 | $467.0M | $2.3B | ||
| Q3 25 | — | $5.0B | ||
| Q2 25 | $239.0M | $5.0B | ||
| Q1 25 | $506.0M | $4.9B | ||
| Q4 24 | $400.0M | $5.0B | ||
| Q3 24 | $416.0M | $3.3B | ||
| Q2 24 | $236.0M | $4.6B |
毛利率CAHVZ
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 3.9% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 3.6% | — | ||
| Q2 24 | 3.1% | — |
营业利润率CAHVZ
| Q1 26 | — | 23.9% | ||
| Q4 25 | 1.1% | 13.8% | ||
| Q3 25 | — | 24.0% | ||
| Q2 25 | 0.7% | 23.7% | ||
| Q1 25 | 1.3% | 23.8% | ||
| Q4 24 | 1.0% | 20.8% | ||
| Q3 24 | 1.1% | 17.8% | ||
| Q2 24 | 0.7% | 23.8% |
净利率CAHVZ
| Q1 26 | — | 14.9% | ||
| Q4 25 | 0.7% | 6.4% | ||
| Q3 25 | — | 14.6% | ||
| Q2 25 | 0.4% | 14.5% | ||
| Q1 25 | 0.9% | 14.6% | ||
| Q4 24 | 0.7% | 14.0% | ||
| Q3 24 | 0.8% | 9.9% | ||
| Q2 24 | 0.4% | 14.0% |
每股收益（稀释后）CAHVZ
| Q1 26 | — | — | ||
| Q4 25 | — | $0.56 | ||
| Q3 25 | — | $1.17 | ||
| Q2 25 | — | $1.18 | ||
| Q1 25 | — | $1.15 | ||
| Q4 24 | — | $1.18 | ||
| Q3 24 | $1.70 | $0.78 | ||
| Q2 24 | $0.86 | $1.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.8B | $8.4B |
| 总债务越低越好 | $8.3B | $144.2B |
| 股东权益账面价值 | $-2.9B | $104.6B |
| 总资产 | $58.1B | $417.9B |
| 负债/权益比越低杠杆越低 | — | 1.38× |
8季度趋势，按日历期对齐
现金及短期投资CAHVZ
| Q1 26 | — | $8.4B | ||
| Q4 25 | $2.8B | $19.0B | ||
| Q3 25 | — | $7.7B | ||
| Q2 25 | $3.9B | $3.4B | ||
| Q1 25 | $3.3B | $2.3B | ||
| Q4 24 | $3.8B | $4.2B | ||
| Q3 24 | $2.9B | $5.0B | ||
| Q2 24 | $5.3B | $2.4B |
总债务CAHVZ
| Q1 26 | — | $144.2B | ||
| Q4 25 | $8.3B | $139.5B | ||
| Q3 25 | — | $126.6B | ||
| Q2 25 | $8.0B | $123.9B | ||
| Q1 25 | $7.1B | $121.0B | ||
| Q4 24 | $7.1B | $121.4B | ||
| Q3 24 | $4.2B | $128.9B | ||
| Q2 24 | $4.7B | $126.0B |
股东权益CAHVZ
| Q1 26 | — | $104.6B | ||
| Q4 25 | $-2.9B | $105.7B | ||
| Q3 25 | — | $106.3B | ||
| Q2 25 | $-2.8B | $104.4B | ||
| Q1 25 | $-2.9B | $102.0B | ||
| Q4 24 | $-3.0B | $100.6B | ||
| Q3 24 | $-3.3B | $97.7B | ||
| Q2 24 | $-3.2B | $97.5B |
总资产CAHVZ
| Q1 26 | — | $417.9B | ||
| Q4 25 | $58.1B | $404.3B | ||
| Q3 25 | — | $388.3B | ||
| Q2 25 | $53.1B | $383.3B | ||
| Q1 25 | $49.9B | $380.4B | ||
| Q4 24 | $47.0B | $384.7B | ||
| Q3 24 | $43.1B | $381.2B | ||
| Q2 24 | $45.1B | $379.1B |
负债/权益比CAHVZ
| Q1 26 | — | 1.38× | ||
| Q4 25 | — | 1.32× | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | 1.19× | ||
| Q1 25 | — | 1.19× | ||
| Q4 24 | — | 1.21× | ||
| Q3 24 | — | 1.32× | ||
| Q2 24 | — | 1.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $8.0B |
| 自由现金流经营现金流 - 资本支出 | — | $3.8B |
| 自由现金流率自由现金流/营收 | — | 11.0% |
| 资本支出强度资本支出/营收 | — | 12.2% |
| 现金转化率经营现金流/净利润 | — | 1.55× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CAHVZ
| Q1 26 | — | $8.0B | ||
| Q4 25 | — | $9.1B | ||
| Q3 25 | — | $11.3B | ||
| Q2 25 | $1.5B | $9.0B | ||
| Q1 25 | $2.9B | $7.8B | ||
| Q4 24 | $-400.0M | $10.4B | ||
| Q3 24 | $-1.6B | $9.9B | ||
| Q2 24 | $2.1B | $9.5B |
自由现金流CAHVZ
| Q1 26 | — | $3.8B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $2.8B | — | ||
| Q4 24 | $-499.0M | — | ||
| Q3 24 | $-1.7B | — | ||
| Q2 24 | $1.9B | — |
自由现金流率CAHVZ
| Q1 26 | — | 11.0% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | -0.9% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 3.2% | — |
资本支出强度CAHVZ
| Q1 26 | — | 12.2% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.3% | — |
现金转化率CAHVZ
| Q1 26 | — | 1.55× | ||
| Q4 25 | — | 3.89× | ||
| Q3 25 | — | 2.28× | ||
| Q2 25 | 6.39× | 1.79× | ||
| Q1 25 | 5.76× | 1.59× | ||
| Q4 24 | -1.00× | 2.08× | ||
| Q3 24 | -3.96× | 3.00× | ||
| Q2 24 | 8.80× | 2.07× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAH
| Pharmaceutical And Specialty Solutions | $60.7B | 92% |
| GMPD | $3.3B | 5% |
| At Home Solutions | $1.2B | 2% |
| Nuclear Precision Health Solutions | $440.0M | 1% |
| Opti Freight Logistics | $99.0M | 0% |
VZ
| Service revenues and other | $28.8B | 84% |
| Wireless equipment revenues | $5.7B | 16% |
